Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole for Clozapine-Associated Medical Morbidity
NCT00345033Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2005
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in insulin resistance (IR), hyperlipidemia, obesity, sponsored by Massachusetts General Hospital. Started Mar 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
insulin resistance (IR)hyperlipidemiaobesity
Beyond the preview
Go deeper on NCT00345033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345033.